Structure (Image 1)
Cephalexin Capsule
Product Images NDC 42291-007
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 42291-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
250mg 500s (Image 2)
This text includes information about a medication with GTIN 00342291006508, containing cephalexin monohydrate in capsules with a dosage recommendation of 250 mg every six hours for adults. There is guidance on increasing the dose for severe infections, storage instructions, prescription information, details about the manufacturer AVKARE, and the expiration date of the product as Rev. A 12/2025. The text also mentions that there are 500 capsules available.*
500mg 500s (Image 3)
This text contains vital information about a medication called Cephalexin monohydrate, in the form of capsules. Each capsule contains 500 mg of cephalexin. The usual adult dosage is 250 mg every six hours, and the dose can be increased for severe infections up to 4 g per day. The medication should be stored at 20°C to 25°C. It should be dispensed in a tightly sealed container with a child-resistant closure. The manufacturer is AVKARE based in Pulaski, TN.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
